UDG Healthcare’s Sharp division outperforms its chief executive’s hopes
The contract clinical, manufacturing, packaging and technology services business sees 34 per cent increase in adjusted operating profit
Twelve months ago, Brendan McAtamney predicted 2020 would prove to be a strong year for UDG Healthcare’s Sharp division.
The group’s chief executive told the Business Post that after closing two of its poorly-performing facilities in the Netherlands, he was confident that its contract clinical, manufacturing, packaging and technology services business could deliver “double-digit growth”.
Last week, McAtamney was able to report that Sharp’s performance over the past year had outstripped even his own positive ...